136 related articles for article (PubMed ID: 35731852)
1. Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single-center experience.
Ferrari A; Bergamaschi L; Chiaravalli S; Livellara V; Sironi G; Nigro O; Puma N; Gattuso G; Morosi C; Gasparini P; Caccavo R; Pecori E; Alessandro O; Vennarini S; Gandola L; Massimino M; Casanova M
Pediatr Blood Cancer; 2022 Nov; 69(11):e29853. PubMed ID: 35731852
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
3. Local treatment in initially unresected non-rhabdomyosarcoma soft-tissue sarcomas of children and adolescents: A retrospective single-center experience.
Ferrari A; Vennarini S; Fiore M; Bergamaschi L; Chiaravalli S; Morosi C; Colombo C; Pecori E; Puma N; Luksch R; Terenziani M; Spreafico F; Meazza C; Podda M; Biassoni V; Schiavello E; Massimino M; Casanova M
Pediatr Blood Cancer; 2024 Apr; 71(4):e30901. PubMed ID: 38296840
[TBL] [Abstract][Full Text] [Related]
4. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma.
Cameron AL; Elze MC; Casanova M; Geoerger B; Gaze MN; Minard-Colin V; McHugh K; van Rijn RR; Kelsey A; Martelli H; Mandeville H; Bisogno G; Lowis S; Ronghe M; Orbach D; Guizani C; Fürst-Recktenwald S; Chisholm JC; Merks JHM;
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):968-978. PubMed ID: 34217789
[TBL] [Abstract][Full Text] [Related]
6. Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.
Bergamaschi L; Bertulli R; Casanova M; Provenzano S; Chiaravalli S; Gasparini P; Collini P; Sangalli C; Gandola L; Diletto B; Morosi C; Fiore M; Massimino M; Ferrari A
Med Oncol; 2019 May; 36(7):59. PubMed ID: 31104202
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Rhabdomyosarcoma: Results of the European
Schoot RA; Chisholm JC; Casanova M; Minard-Colin V; Geoerger B; Cameron AL; Coppadoro B; Zanetti I; Orbach D; Kelsey A; Rogers T; Guizani C; Elze M; Ben-Arush M; McHugh K; van Rijn RR; Ferman S; Gallego S; Ferrari A; Jenney M; Bisogno G; Merks JHM
J Clin Oncol; 2022 Nov; 40(32):3730-3740. PubMed ID: 35709412
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98.
McDowell HP; Foot AB; Ellershaw C; Machin D; Giraud C; Bergeron C
Eur J Cancer; 2010 Jun; 46(9):1588-95. PubMed ID: 20338746
[TBL] [Abstract][Full Text] [Related]
9. Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables.
Bergamaschi L; Chiaravalli S; Livellara V; Sironi G; Puma N; Nigro O; Gattuso G; Luksch R; Terenziani M; Spreafico F; Meazza C; Podda M; Biassoni V; Schiavello E; Hovsepyan S; Morosi C; Vennarini S; Massimino M; Casanova M; Ferrari A
Pediatr Blood Cancer; 2023 Jan; 70(1):e30050. PubMed ID: 36215173
[TBL] [Abstract][Full Text] [Related]
10. Durability of oncological outcomes of combination chemotherapy as a monotherapy for a select patient subset with non-metastatic non-alveolar bladder/prostate rhabdomyosarcoma.
Abdelhalim A; Atwa AM; Helmy TE; Dawaba ME; Elashry R; Hafez AT
J Pediatr Urol; 2021 Aug; 17(4):535.e1-535.e8. PubMed ID: 34092511
[TBL] [Abstract][Full Text] [Related]
11. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA
J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
Liu YT; Wang CW; Hong RL; Kuo SH
Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
[TBL] [Abstract][Full Text] [Related]
14. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
15. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
16. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
[TBL] [Abstract][Full Text] [Related]
17. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.
Weigel BJ; Breitfeld PP; Hawkins D; Crist WM; Baker KS
J Pediatr Hematol Oncol; 2001; 23(5):272-6. PubMed ID: 11464981
[TBL] [Abstract][Full Text] [Related]
18. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?
Schuck A; Mattke AC; Schmidt B; Kunz DS; Harms D; Knietig R; Treuner J; Koscielniak E
J Clin Oncol; 2004 Jan; 22(1):143-9. PubMed ID: 14701776
[TBL] [Abstract][Full Text] [Related]
19. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
Ferrari A; Dileo P; Casanova M; Bertulli R; Meazza C; Gandola L; Navarria P; Collini P; Gronchi A; Olmi P; Fossati-Bellani F; Casali PG
Cancer; 2003 Aug; 98(3):571-80. PubMed ID: 12879475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
